The Supreme Court has spoken. In an expected reaction from the nation's highest court, justices unanimously ruled to preserve access to the abortion drug, mifepristone. The nation's highest court said the pro-life groups lacked the legal right to sue the FDA's approval of the medication. The plaintiffs argued the FDA's decisions to allow the drug to be used without an in-person doctor's visit jeopardized women's health. Supreme Court Justice Brett Kavanaugh, a Catholic, wrote the unanimous opinion, saying in part, "Plaintiffs are pro-life, oppose elective abortion, and have sincere legal, moral, ideological, and policy objections to mifepristone being prescribed and used by others." An Appellate Attorney and Former Assistant Solicitor General in Texas who filed an amicus brief in this case, Heather Hacker, joins to share whether she was surprised by the justices' decision. Hacker tells us more about the doctors and the medical associations in this case being told they did not have "standing" in this case. She explains what this means for Danco Laboratories, the pharmaceutical company that produces mifepristone.
------------
EWTN News Nightly provides the latest news and analysis from a Catholic perspective. Join host Tracy Sabol, our Capitol Hill, White House and Rome Correspondents, as well as many other diverse guests daily, to get the latest from the U.S. and the Vatican on topics regarding our Catholic faith and interests.
-------------
EWTN News Nightly airs on EWTN weekdays at 6pm & 9pm ET.
------------
Don't miss an episode of EWTN New Nightly. Get updates here:
[ Ссылка ]
-------------
Sign up today to receive the EWTN News Nightly newsletter:
[ Ссылка ]
-------------
Follow EWTN News Nightly on Social Media:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
-------------
Subscribe to EWTN YouTube channel here:
[ Ссылка ]
-------------
You can support the EWTN News mission:
[ Ссылка ]
